|
Marizyme Inc
MARZ's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Marizyme Inc 's sales fell
in II. Quarter 2024 from the same quarter a year ago.
Ranking at No. 348
Medical Equipment & Supplies industry recorded
growth of revenues by 2.42 %
Marizyme Inc net loss decreased from $-21 millions, to $-4 millions in II. Quarter 2024,
• More on MARZ's Growth
|
|
Marizyme Inc realized a net loss in trailing twelve months.
Marizyme Inc realized cash reduction of $ -0 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 12176.97.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.32.
• More on MARZ's Valuation
|
|
|
|
|
Marizyme Inc realized net loss in trailing twelve months.
Marizyme Inc realized cash outflow of $ -0per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 12176.97.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.32.
• More on MARZ's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com